Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale.
Culture viraleDiagnostic viral
#2
Quels échantillons sont utilisés pour la culture virale ?
Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies.
Échantillons biologiquesCulture virale
#3
Quels tests complètent la culture virale ?
Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale.
Tests de laboratoireDiagnostic viral
#4
Combien de temps prend une culture virale ?
La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus.
Culture viraleTemps de culture
#5
Quels signes indiquent une infection virale dans une culture ?
L'apparition de cytopathies ou de plaques de lyse indique une infection virale.
Infection viraleCulture virale
Symptômes
5
#1
Quels symptômes peuvent indiquer une infection virale ?
Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents.
SymptômesInfection virale
#2
Les symptômes varient selon le virus ?
Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme.
VirusSymptômes
#3
Comment les symptômes évoluent-ils avec une infection virale ?
Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire.
Réponse immunitaireInfection virale
#4
Les symptômes sont-ils toujours présents lors d'une culture virale ?
Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture.
AsymptomatiqueCulture virale
#5
Quels symptômes nécessitent une culture virale urgente ?
Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture.
Urgence médicaleCulture virale
Prévention
5
#1
Comment prévenir les infections virales ?
Vaccination, hygiène des mains et éviter le contact avec des personnes infectées.
PréventionVaccination
#2
Les vaccins sont-ils efficaces contre tous les virus ?
Non, chaque vaccin cible des virus spécifiques et leur efficacité varie.
VaccinsPrévention
#3
Quelles mesures d'hygiène sont recommandées ?
Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées.
HygiènePrévention
#4
Les masques aident-ils à prévenir les infections virales ?
Oui, les masques réduisent la transmission des virus respiratoires.
MasquesPrévention
#5
Les voyages augmentent-ils le risque d'infection virale ?
Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies.
VoyagesInfection virale
Traitements
5
#1
Quels traitements sont disponibles pour les infections virales ?
Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés.
AntivirauxTraitement antiviral
#2
La culture virale aide-t-elle à choisir un traitement ?
Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux.
Culture viraleTraitement antiviral
#3
Les antibiotiques sont-ils efficaces contre les virus ?
Non, les antibiotiques ne sont efficaces que contre les infections bactériennes.
AntibiotiquesInfection virale
#4
Comment les antiviraux agissent-ils ?
Ils inhibent la réplication virale ou modulent la réponse immunitaire.
AntivirauxRéponse immunitaire
#5
Les traitements sont-ils les mêmes pour tous les virus ?
Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie.
VirusTraitement antiviral
Complications
5
#1
Quelles complications peuvent survenir après une infection virale ?
Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir.
ComplicationsInfection virale
#2
Les complications sont-elles prévisibles ?
Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient.
ComplicationsÉtat de santé
#3
Comment les complications sont-elles traitées ?
Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques.
TraitementComplications
#4
Les enfants sont-ils plus à risque de complications ?
Oui, certains virus peuvent entraîner des complications plus graves chez les enfants.
EnfantsComplications
#5
Les personnes âgées sont-elles plus vulnérables aux complications ?
Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications.
Personnes âgéesComplications
Facteurs de risque
5
#1
Quels facteurs augmentent le risque d'infection virale ?
Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque.
Facteurs de risqueInfection virale
#2
L'âge influence-t-il le risque d'infection virale ?
Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales.
ÂgeInfection virale
#3
Les maladies chroniques augmentent-elles le risque ?
Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection.
Maladies chroniquesFacteurs de risque
#4
Le mode de vie influence-t-il le risque d'infection virale ?
Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque.
Mode de vieFacteurs de risque
#5
Les voyages à l'étranger augmentent-ils le risque d'infection ?
Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement.
VoyagesInfection virale
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Culture virale : Questions médicales les plus fréquentes",
"headline": "Culture virale : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Culture virale : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-03-13",
"dateModified": "2025-03-08",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Culture virale"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Techniques microbiologiques",
"url": "https://questionsmedicales.fr/mesh/D008828",
"about": {
"@type": "MedicalCondition",
"name": "Techniques microbiologiques",
"code": {
"@type": "MedicalCode",
"code": "D008828",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875"
}
}
},
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Méthode des plages virales",
"alternateName": "Viral Plaque Assay",
"url": "https://questionsmedicales.fr/mesh/D010948",
"about": {
"@type": "MedicalCondition",
"name": "Méthode des plages virales",
"code": {
"@type": "MedicalCode",
"code": "D010948",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "E05.200.875.970.790"
}
}
}
],
"about": {
"@type": "MedicalCondition",
"name": "Culture virale",
"alternateName": "Virus Cultivation",
"code": {
"@type": "MedicalCode",
"code": "D014776",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Arvind Varsani",
"url": "https://questionsmedicales.fr/author/Arvind%20Varsani",
"affiliation": {
"@type": "Organization",
"name": "2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA."
}
},
{
"@type": "Person",
"name": "Giacomo Fais",
"url": "https://questionsmedicales.fr/author/Giacomo%20Fais",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Mattia Casula",
"url": "https://questionsmedicales.fr/author/Mattia%20Casula",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Pierluigi Caboni",
"url": "https://questionsmedicales.fr/author/Pierluigi%20Caboni",
"affiliation": {
"@type": "Organization",
"name": "Department of Life and Environmental Sciences, University of Cagliari, 09042 Cagliari, Italy."
}
},
{
"@type": "Person",
"name": "Giacomo Cao",
"url": "https://questionsmedicales.fr/author/Giacomo%20Cao",
"affiliation": {
"@type": "Organization",
"name": "Interdepartmental Centre of Environmental Science and Engineering (CINSA), University of Cagliari, Via San Giorgio 12, 09124 Cagliari, Italy."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "The influence of Medicare Part D on the list pricing of brand drugs.",
"datePublished": "2023-02-19",
"url": "https://questionsmedicales.fr/article/36737865",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1111/1475-6773.14139"
}
},
{
"@type": "ScholarlyArticle",
"name": "Role of Specialty Drugs in Rising Drug Prices for Medicare Part D.",
"datePublished": "2024-05-03",
"url": "https://questionsmedicales.fr/article/38787543",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1001/jamahealthforum.2024.1188"
}
},
{
"@type": "ScholarlyArticle",
"name": "Utilization Management in the Medicare Part D Program and Prescription Drug Utilization.",
"datePublished": "2022-10-04",
"url": "https://questionsmedicales.fr/article/36194915",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1515/fhep-2022-0007"
}
},
{
"@type": "ScholarlyArticle",
"name": "Assessing the Trends of Tramadol Utilization in the Medicare Part D Population in Rhode Island.",
"datePublished": "2024-05-02",
"url": "https://questionsmedicales.fr/article/38687267",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": null
}
},
{
"@type": "ScholarlyArticle",
"name": "Solving racial/ethnic disparities associated with Medicare Part D Star Ratings.",
"datePublished": "2023-06-05",
"url": "https://questionsmedicales.fr/article/37219396",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1080/03007995.2023.2217654"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Techniques d'investigation",
"item": "https://questionsmedicales.fr/mesh/D008919"
},
{
"@type": "ListItem",
"position": 3,
"name": "Techniques de laboratoire clinique",
"item": "https://questionsmedicales.fr/mesh/D019411"
},
{
"@type": "ListItem",
"position": 4,
"name": "Techniques microbiologiques",
"item": "https://questionsmedicales.fr/mesh/D008828"
},
{
"@type": "ListItem",
"position": 5,
"name": "Culture virale",
"item": "https://questionsmedicales.fr/mesh/D014776"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Culture virale - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Culture virale",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Culture virale",
"description": "Comment se déroule un test de culture virale ?\nQuels échantillons sont utilisés pour la culture virale ?\nQuels tests complètent la culture virale ?\nCombien de temps prend une culture virale ?\nQuels signes indiquent une infection virale dans une culture ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Medicare+Part+D#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Culture virale",
"description": "Quels symptômes peuvent indiquer une infection virale ?\nLes symptômes varient selon le virus ?\nComment les symptômes évoluent-ils avec une infection virale ?\nLes symptômes sont-ils toujours présents lors d'une culture virale ?\nQuels symptômes nécessitent une culture virale urgente ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Medicare+Part+D#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Culture virale",
"description": "Comment prévenir les infections virales ?\nLes vaccins sont-ils efficaces contre tous les virus ?\nQuelles mesures d'hygiène sont recommandées ?\nLes masques aident-ils à prévenir les infections virales ?\nLes voyages augmentent-ils le risque d'infection virale ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Medicare+Part+D#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Culture virale",
"description": "Quels traitements sont disponibles pour les infections virales ?\nLa culture virale aide-t-elle à choisir un traitement ?\nLes antibiotiques sont-ils efficaces contre les virus ?\nComment les antiviraux agissent-ils ?\nLes traitements sont-ils les mêmes pour tous les virus ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Medicare+Part+D#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Culture virale",
"description": "Quelles complications peuvent survenir après une infection virale ?\nLes complications sont-elles prévisibles ?\nComment les complications sont-elles traitées ?\nLes enfants sont-ils plus à risque de complications ?\nLes personnes âgées sont-elles plus vulnérables aux complications ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Medicare+Part+D#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Culture virale",
"description": "Quels facteurs augmentent le risque d'infection virale ?\nL'âge influence-t-il le risque d'infection virale ?\nLes maladies chroniques augmentent-elles le risque ?\nLe mode de vie influence-t-il le risque d'infection virale ?\nLes voyages à l'étranger augmentent-ils le risque d'infection ?",
"url": "https://questionsmedicales.fr/mesh/D014776?mesh_terms=Medicare+Part+D#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment se déroule un test de culture virale ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un échantillon est inoculé sur un milieu de culture pour observer la croissance virale."
}
},
{
"@type": "Question",
"name": "Quels échantillons sont utilisés pour la culture virale ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les échantillons peuvent inclure du sang, des sécrétions respiratoires ou des biopsies."
}
},
{
"@type": "Question",
"name": "Quels tests complètent la culture virale ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et PCR sont souvent utilisés pour confirmer l'infection virale."
}
},
{
"@type": "Question",
"name": "Combien de temps prend une culture virale ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "La culture virale peut prendre de quelques jours à plusieurs semaines selon le virus."
}
},
{
"@type": "Question",
"name": "Quels signes indiquent une infection virale dans une culture ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'apparition de cytopathies ou de plaques de lyse indique une infection virale."
}
},
{
"@type": "Question",
"name": "Quels symptômes peuvent indiquer une infection virale ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, fatigue, toux, douleurs musculaires et éruptions cutanées sont fréquents."
}
},
{
"@type": "Question",
"name": "Les symptômes varient selon le virus ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, chaque virus peut provoquer des symptômes spécifiques selon son tropisme."
}
},
{
"@type": "Question",
"name": "Comment les symptômes évoluent-ils avec une infection virale ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes peuvent s'aggraver ou s'améliorer selon la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les symptômes sont-ils toujours présents lors d'une culture virale ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Pas nécessairement, certains virus peuvent être asymptomatiques lors de la culture."
}
},
{
"@type": "Question",
"name": "Quels symptômes nécessitent une culture virale urgente ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes graves comme une détresse respiratoire ou une méningite justifient une culture."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections virales ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène des mains et éviter le contact avec des personnes infectées."
}
},
{
"@type": "Question",
"name": "Les vaccins sont-ils efficaces contre tous les virus ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque vaccin cible des virus spécifiques et leur efficacité varie."
}
},
{
"@type": "Question",
"name": "Quelles mesures d'hygiène sont recommandées ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Se laver les mains régulièrement et désinfecter les surfaces fréquemment touchées."
}
},
{
"@type": "Question",
"name": "Les masques aident-ils à prévenir les infections virales ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les masques réduisent la transmission des virus respiratoires."
}
},
{
"@type": "Question",
"name": "Les voyages augmentent-ils le risque d'infection virale ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les voyages peuvent exposer à de nouveaux virus et à des épidémies."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour les infections virales ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les antiviraux, les immunoglobulines et les traitements symptomatiques sont utilisés."
}
},
{
"@type": "Question",
"name": "La culture virale aide-t-elle à choisir un traitement ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle permet d'identifier le virus et de déterminer la sensibilité aux antiviraux."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre les virus ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont efficaces que contre les infections bactériennes."
}
},
{
"@type": "Question",
"name": "Comment les antiviraux agissent-ils ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils inhibent la réplication virale ou modulent la réponse immunitaire."
}
},
{
"@type": "Question",
"name": "Les traitements sont-ils les mêmes pour tous les virus ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, chaque virus peut nécessiter un traitement spécifique selon sa biologie."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir après une infection virale ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications comme la pneumonie, la méningite ou des syndromes post-viraux peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles prévisibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévisibles selon le virus et l'état de santé du patient."
}
},
{
"@type": "Question",
"name": "Comment les complications sont-elles traitées ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le traitement dépend de la complication, allant des soins de soutien à des interventions spécifiques."
}
},
{
"@type": "Question",
"name": "Les enfants sont-ils plus à risque de complications ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certains virus peuvent entraîner des complications plus graves chez les enfants."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables aux complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées ont un système immunitaire affaibli, augmentant le risque de complications."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infection virale ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un système immunitaire affaibli, le stress, et des conditions de vie insalubres augmentent le risque."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque d'infection virale ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les jeunes enfants et les personnes âgées sont plus susceptibles aux infections virales."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le diabète ou les maladies pulmonaires augmentent le risque d'infection."
}
},
{
"@type": "Question",
"name": "Le mode de vie influence-t-il le risque d'infection virale ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un mode de vie sédentaire et une mauvaise alimentation peuvent augmenter le risque."
}
},
{
"@type": "Question",
"name": "Les voyages à l'étranger augmentent-ils le risque d'infection ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, voyager dans des zones endémiques expose à des virus non rencontrés localement."
}
}
]
}
]
}
2The Biodesign Center of Fundamental and Applied Microbiomics, School of Life Sciences, Center for Evolution and Medicine, Arizona State University, 1001 S. McAllister Ave, Tempe, AZ 85287-5001 USA.
3Structural Biology Research Unit, Department of Integrative Biomedical Sciences, University of Cape Town, Observatory, Cape Town, South Africa.
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America; College of Life Science, Qingdao University, Qingdao, PR China.
Department of Food Science, Center for Food Safety, University of Arkansas System Division of Agriculture, Fayetteville, AR 72704, United States of America. Electronic address: keg005@uark.edu.
To compare the Medicare Part D market share of brand drugs with their net-to-list price ratio....
SSR Health Brand Net Price Tool and Medical Expenditure Panel Survey, 2007-2019....
For each drug, we calculated the ratio of net to list price and the percent of users that were Medicare-eligible. We compared these cross-sectionally in each year and estimated a difference-in-differe...
The sample included brand drugs without generic competitors appearing in both datasets....
Net-to-list price ratios were negatively correlated with MMS in the later years of our sample. In 2019, a 10% increase in MMS was associated with a significant 4.6% [95% CI: 2.1%, 7.1%] decrease in ne...
Greater exposure to the Medicare Part D market was associated with larger differences between net and list prices of drugs....
Prices for brand-name drugs affect both federal spending and out-of-pocket liability for Medicare Part D enrollees....
To examine how prices for brand-name drugs, net of rebates and discounts, have changed from 2010 to 2019 and to examine the role of specialty drugs in those changes....
This study involved a descriptive analysis of prescription drug spending and prices between 2010 and 2019. The universe of prescription drug event data from those years were combined with confidential...
Average prices (net of rebates and discounts in 2019 US dollars) and average annual price growth for brand-name prescription drugs, overall and separately for specialty and nonspecialty drugs....
Average net prices for brand-name drugs doubled from 2010 to 2019 (from $167 to $370). Growth in specialty drug prices was an underlying factor in those increases: average annual price growth was 13.2...
Results of this study show that prices for specialty drugs have continued to increase over time in the Medicare Part D program, which contributes to high out-of-pocket liability for users of those dru...
Medicare Part D has significantly enhanced access to prescription drugs among Medicare beneficiaries. However, the recent rapid rise of utilization management policies in the Medicare Part D program m...
To assess the trends in tramadol dispensing among Medicare Part D patients in Rhode Island....
An analysis was conducted of the Medicare Part D Provider Utilization and Payment Data Public Use File for the years 2013-2021. Chi squared tests were conducted to assess statistical significance of a...
Following tramadol becoming a controlled substance in 2014, the number of dispensed tramadol prescriptions and patients with a tramadol prescription decreased every subsequent year through 2021 (presc...
Tramadol utilization has been decreasing among the Medicare Part D population in Rhode Island while the percentage of opioid dispensings that were tramadol have been increasing. Future studies are nee...
Medicare Part D Star Ratings are instrumental in shaping healthcare quality improvement efforts. However, the calculation metrics for medication performance measures for this program have been associa...
We conducted an analysis of a 10% random sample of Medicare A/B/D claims linked to the Area Health Resources File. Multivariate logistic regressions with minority dummy variables were used to examine ...
Adjusted results indicated that relative to non-Hispanic Whites (Whites), racial/ethnic minorities had significantly lower odds of being included in the Star Ratings measure calculations: the odds rat...
Our study demonstrated that racial/ethnic disparities may be eliminated by including additional medication performance measures to Star Ratings....
Despite controversy surrounding the 340B program, no study has analyzed trends in the proportion of Medicare Part D pharmacy claims eligible for 340B discounts....
To describe trends in the proportion of Medicare Part D claims that are prescribed by 340B-affiliated clinicians and filled in 340B pharmacies....
This longitudinal, retrospective cohort study included 2013 to 2020 claims data from a 5% random sample of Medicare Part D beneficiaries from the Centers for Medicare & Medicaid Services and 6292 nine...
For each drug and year, there were 3 outcomes: (1) proportion of total Part D claims that were prescribed by a 340B-affiliated clinician; (2) proportion of claims prescribed by a 340B-affiliated clini...
The proportion of prescriptions written by a 340B-affiliated clinician doubled from 9.4% in 2013 to 19.3% in 2020. The capture of 340B prescriptions by 340B pharmacies, defined as the proportion of cl...
This cohort study demonstrated that from 2013 to 2020, the share of Medicare Part D claims prescribed by a 340B-affiliated clinician increased; however, the rate at which 340B-eligible prescriptions w...
The Affordable Care Act included a provision to gradually eliminate the Medicare prescription drug coverage gap between 2011 and 2020, which substantially lower medication costs in the gap. Using 2007...
Little is known about how out-of-pocket burden differs between Medicare and commercial insurance for ultra-expensive drugs....
To investigate out-of-pocket spending for ultra-expensive drugs in the Medicare Part D program vs commercial insurance....
This was a retrospective, population-based cohort study of individuals using ultra-expensive drugs included in a 20% nationally random sample of prescription drug claims from Medicare Part D and indiv...
Claims-weighted mean out-of-pocket spending per beneficiary per drug by insurance type, plan, and age....
In 2019, 37 324 and 24 159 individuals using ultra-expensive drugs were identified in the 20% Part D and commercial samples, respectively (mean [SD] age, 66.2 [11.7] years; 54.9% female). A statistica...
This cohort study demonstrated that the $2000 out-of-pocket cap included in the Inflation Reduction Act may substantially moderate the potential increase in spending faced by individuals who use ultra...
This paper documents how substance abuse treatment (SAT) providers and services respond to increases in population-level opioid addiction. I do this by exploiting the implementation of Medicare Part D...
Benzodiazepine use among older adults is discouraged....
We analyzed the Medicare Part D Prescribers by Provider and Drug dataset to determine the number of benzodiazepine claims per 100 Medicare enrollees for each NE state between 2016-2020, and to determi...
Rhode Island led all NE states the with highest annual rates of Part D benzodiazepine claims for all years from 2016 to 2020. Benzodiazepine claims decreased in all NE states over the 5-year period. I...
While Part D benzodiazepine claims declined between 2016-2020, the overall volume of dispensings suggests that these medications remain overprescribed among older adults. Our findings underscore the n...